EUVIMEDOpdag EUVIMED
MetaanalyseSystematische Übersicht

Impact of omega‐3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta‐analysis of randomized‐controlled trials

Mohammad Hassan Sohouli iD, Elma Izze da Silva Magalhães, Sara Ghahramani, Maryam Nasresfahani, Neda Ezoddin, Parastoo Sharifi, Pejman Rohani

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26491 ↗

At a glance

Metaanalyse in Pediatric Pulmonology, 2023. Written by Mohammad Hassan Sohouli and 6 co-authors. Institution: Student Research Committee, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of M…. Major MEDLINE topics: Cystic Fibrosis, Fatty Acids, Omega-3. Cited 4 times so far (Crossref); 28 references. Funded by: Research and Technology Chancellor of Tehran University of Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Clinical trial research have provided evidence that omega‐3 may have larger potential benefits for treating cystic fibrosis (CF). This study's objective was to assess the impact of three supplementation on pediatric CF patients.

Methods

Scopus, PubMed/Medline, Web of Science, Cochrane, and Embase databases were searched from commencement until July 20, 2022 using standard keywords to identify all randomized controlled studies (RCTs) examining the effects of omega‐3 supplementation on young patients with CF. The eligible studies were subjected to a random‐effects model meta‐analysis.

Results

A meta‐analysis of 12 the eligible studies was performed. Findings of the study showed that omega‐3 supplementation significantly increased the levels of docosahexaenoic acid (weighted mean [WMD]: 2.06%, 95% confidence interval [CI]: 1.29, 2.82, p < 0.001) and eicosapentaenoic acid (WMD: 0.32%, 95% CI: 0.15, 0.48, p < 0.001) as well as decreased arachidonic acid (WMD: −0.78%, 95% CI: −1.50, −0.05, p = 0.035) and C‐receptive protein (CRP) (WMD: −3.76 mg/L, 95% CI: −7.42, −0.10, p = 0.044) especially when used in higher doses and for a longer period of time compared to the control group. However, no significant effect was observed on other factors including forced expiratory volume 1, forced vital capacity as well as anthropometric parameters. In addition, high heterogeneity was reported for all fatty acids, but heterogeneity was low and nonsignificant for other variables.

Conclusion

The finding showed that in pediatric patients with CF, omega‐3 supplementation showed benefits only in plasma fatty acid profile and serum CRP.

Subjects

MeSH terms (MEDLINE)

Cystic FibrosisFatty Acids, Omega-3HumansChildAdolescentDietary SupplementsAnthropometryRandomized Controlled Trials as Topic

Author keywords

FEVcystic fibrosisinflammationmeta-analysisomega-3 supplementationpediatrics

Substances

Fatty Acids, Omega-3

Authors and institutions

  • Student Research Committee, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Pediatric Gastroenterology and Hepatology Research Center, Department of Pediatric, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Postgraduate Programm in Food, Nutrition and Health, Department of Clinical Nutrition and Dietetics, Federal University of Rio Grande do Sul, São Luís, MA, Brazil.
  • Pediatric Respiratory and Sleep Medicine Research Center, Department of Pediatric, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Pediatric Gastroenterology and Hepatology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID profiles: Mohammad Hassan Sohouli

Funding

  • Research and Technology Chancellor of Tehran University of Medical Sciences

Cite

APA

Sohouli, M. H., Magalhães, E. I. D. S., Ghahramani, S., Nasresfahani, M., Ezoddin, N., Sharifi, P., & Rohani, P. (2023). Impact of omega‐3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta‐analysis of randomized‐controlled trials. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26491

Vancouver

Sohouli MH, Magalhães EIDS, Ghahramani S, Nasresfahani M, Ezoddin N, Sharifi P, et al. Impact of omega‐3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta‐analysis of randomized‐controlled trials. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26491

BibTeX
@article{Sohouli2023,
  author = {Sohouli, Mohammad Hassan and Magalhães, Elma Izze da Silva and Ghahramani, Sara and Nasresfahani, Maryam and Ezoddin, Neda and Sharifi, Parastoo and Rohani, Pejman},
  title = {Impact of omega‐3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta‐analysis of randomized‐controlled trials},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26491}
}
Start for free →